Adlay polysaccharides targeting S100A4 are an alternative cancer chemotherapy, and inhibit migration and invasion of A549 cells by downregulation of S100A4, as well as possibly interacting with the binding site of S100A4-NMIIA [49]. Here, S100A4 is linked to cancer.